Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 410.36 million compared to INR 434.38 million a year ago. Revenue was INR 413.74 million compared to INR 439.4 million a year ago. Net income was INR 28.5 million compared to INR 24.6 million a year ago. Basic earnings per share from continuing operations was INR 0.225 compared to INR 0.194 a year ago. Diluted earnings per share from continuing operations was INR 0.225 compared to INR 0.194 a year ago.